Characteristics of XDR-TB patients in Israel: 2000-2010

D. Bendayan, A. Hendler, K. Litman (Beer Yaakov, Israel)

Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Bendayan, A. Hendler, K. Litman (Beer Yaakov, Israel). Characteristics of XDR-TB patients in Israel: 2000-2010. Eur Respir J 2011; 38: Suppl. 55, 3304

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment outcome of XDR-TB patients in Iran during 2003-2006
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008

Treatment outcomes of MDR-TB patients notified in Romania during 2005-2007
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011

Profile of TB deaths in Romania during 2007-2009
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011

MDR TB in Azerbaijan, 2006-2007
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008

TB by Euro-regions in Romania, between 2006-2008
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010

Treatment outcomes of MDR-TB cases registered in Bucharest sector 4 during 2004-2008
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012


Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004
Source: Eur Respir J 2010; 36: 584-593
Year: 2010



Trends in tuberculosis in Romania between 2001-2006
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008


Epidemiology of tuberculosis (TB) in Poland in the period 1994-2003
Source: Eur Respir J 2005; 26: Suppl. 49, 191s
Year: 2005

Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999
Source: Eur Respir J 2001; 18: Suppl. 33, 513s
Year: 2001

Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017


The epidemiological characteristics of tuberculosis (TB) in Romania between 2000-2008
Source: Annual Congress 2010 - Tuberculosis epidemiology
Year: 2010


MDR and XDR-TB in Vojvodina province (Serbia) during 2000-2009
Source: Annual Congress 2010 - Various aspects of respiratory epidemiology
Year: 2010


Clinical evaluation of patients with tuberculosis in Slovakia - Martin region in 1995-1999
Source: Eur Respir J 2003; 22: Suppl. 45, 155s
Year: 2003

Study of drug-resistant tuberculosis in Plovdiv region, Bulgaria - 1989-2003
Source: Eur Respir J 2005; 26: Suppl. 49, 651s
Year: 2005

Analysis of TB denotifications in North London (2003 – 2012)
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013


Evaluation of 934 tuberculosis patients enrolled to esrefpasa tuberculosis dispensary (1996-2001)
Source: Eur Respir J 2002; 20: Suppl. 38, 364s
Year: 2002

Resistance pattern of tuberculosis patients enrolled to Izmir esrefpasa tuberculosis dispensary between 1996-2001
Source: Eur Respir J 2002; 20: Suppl. 38, 615s
Year: 2002

Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013


TB epidemiology and drug resistance in Bulgaria (1990-2003)
Source: Eur Respir J 2004; 24: Suppl. 48, 199s
Year: 2004